Fotios Plakogiannis
Oprichter bij Transdermal Research Pharm Laboratories LLC
Actieve functies van Fotios Plakogiannis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Transdermal Research Pharm Laboratories LLC | Oprichter | 01-01-2013 | - |
| President | 01-01-2013 | - | |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Directeur/Bestuurslid | - | - |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Directeur/Bestuurslid | - | - |
Loopbaan van Fotios Plakogiannis
Eerdere bekende functies van Fotios Plakogiannis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AEQUUS PHARMACEUTICALS INC. | Directeur/Bestuurslid | 03-01-2014 | 10-07-2018 |
| Voorzitter | 25-02-2013 | 10-12-2014 | |
| Oprichter | 03-01-2013 | 10-07-2018 | |
| Long Island University | Corporate Officer/Principal | 01-01-1967 | 01-01-2011 |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Corporate Officer/Principal | - | - |
Opleiding van Fotios Plakogiannis
| The Ohio State University | Graduate Degree |
| University of Southern California | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Canada | 2 |
Operationeel
| Director/Board Member | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AEQUUS PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Transdermal Research Pharm Laboratories LLC | |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
- Beurs
- Insiders
- Fotios Plakogiannis
- Ervaring